Eli Lilly Partners with Camurus on Long-Acting Cardiovascular and Metabolic Health Products
CompanyDeals

Eli Lilly Partners with Camurus on Long-Acting Cardiovascular and Metabolic Health Products

CirCode Biomed's Circular RNA Drug HM2002 Approved for US Clinical Trials
CompanyDrug

CirCode Biomed’s Circular RNA Drug HM2002 Approved for US Clinical Trials

Bio-heart Launches Iberis Renal Ablation System at OCC 2025
CompanyMedical Device

Bio-heart Launches Iberis Renal Ablation System at OCC 2025

BioAge Labs Partners with JiKang for APJ Agonist Nanobody License
CompanyDeals

BioAge Labs Partners with JiKang for APJ Agonist Nanobody License

Bayer's Nubeqa Gets FDA Approval for mHSPC Treatment
CompanyDrug

Bayer’s Nubeqa Gets FDA Approval for mHSPC Treatment

Sainte Nutritional Files for IPO in Hong Kong as FSMP Pioneer
CompanyDeals

Sainte Nutritional Files for IPO in Hong Kong as FSMP Pioneer

Sino Biopharmaceutical Presents CAMPASS Phase III Results at ASCO 2025
CompanyDrug

Sino Biopharmaceutical Presents CAMPASS Phase III Results at ASCO 2025

Harbin Gloria Partners with Eisai to Promote Methycobal in China
CompanyDeals

Harbin Gloria Partners with Eisai to Promote Methycobal in China

Lepu Medical Wins NMPA Approval for Polylactic Acid Facial Filler
CompanyDrug

Lepu Medical Wins NMPA Approval for Polylactic Acid Facial Filler

JNJ Reveals Positive AMPLITUDE Phase III Results for Akeega in mHSPC at ASCO 2025
CompanyDrug

JNJ Reveals Positive AMPLITUDE Phase III Results for Akeega in mHSPC at ASCO 2025

Hansoh Pharma's Almonertinib Approved in UK for EGFR-Mutated NSCLC
CompanyDrug

Hansoh Pharma’s Almonertinib Approved in UK for EGFR-Mutated NSCLC

EU Bars Chinese Medical Device Makers from Public Tenders Over €5M for Five Years
CompanyMedical Device

EU Bars Chinese Medical Device Makers from Public Tenders Over €5M for Five Years